Biocon Biologics

Biocon Biologics was proud to participate in the 4th Annual BIRD Congress in Brussels, the landmark IBD event bringing together Belgian gastroenterologists and IBD nurses dedicated to transforming care for patients with inflammatory bowel diseases.   This prestigious two-day congress provided invaluable opportunities for scientific exchange, featuring educational workshops on treatment optimisation, preventive medicine, and the latest research developments. This occasion reinforced our commitment to the gastroenterology community, where collaboration between industry, clinicians, and researchers drives progress in IBD management.   Thank you to everyone who contributed to these valuable exchanges during this gathering.   Together, we're shaping sustainable gastroenterology care.   #BioconBiologicsEurope #BIRDCongress #IBD #Gastroenterology #Biosimilars #Belgium

We often notice every little alert on our screens - but can miss the subtle ones from our own body. Fatigue, thirst, slow healing - small signs that can mean something more. This Diabetes Awareness Month, take a moment to view what your body may be saying. Because the earlier diabetes is recognised, the easier it is to manage, control, and even prevent. #ClickRightOnDiabetes #BioconBiologics #DiabetesAwareness #DiabetesEducation #KnowYourNumbers #EarlyDetection #GlucoseManagement #ChronicCare #PatientAwareness #HealthcareEducation

Biocon Biologics was honoured to participate in the 27th Annual Meeting of the Croatian Rheumatology Society in Dubrovnik, where nearly 400 healthcare professionals from Croatia, Slovenia, Serbia, and Bosnia and Herzegovina came together. This prestigious gathering reinforced the vital role of regional collaboration in advancing rheumatology care across the Balkans. Our Croatia team engaged in meaningful conversations with rheumatologists from all participating countries, strengthening partnerships that directly benefit patients with rheumatic diseases. We're particularly proud to be recognised as a trusted partner to healthcare professionals across the region. These connections are essential for our mission: expanding access to biosimilars whilst supporting healthcare system sustainability. Together, we're advancing rheumatology care across Europe.  #BioconBiologicsEurope #Rheumatology #Biosimilars #Croatia #Healthcare

Early screening isn’t just a precaution - it’s prevention in progress.   With regular testing and adhering to therapeutic lifestyle changes where the risks can be caught before they grow, the chance of progression can drop by 58%.   Let’s make the checkup a habit, not an afterthought.   #ClickRightOnDiabetes #BioconBiologics #DiabetesAwareness #DiabetesEducation #KnowYourNumbers #EarlyDetection #GlucoseManagement #ChronicCare #PatientAwareness #HealthcareEducation

Biocon Biologics Wins Golden Peacock Award for Excellence in Corporate Governance 2025   We are proud to share that Biocon Biologics has been awarded the Golden Peacock Award for Excellence in Corporate Governance 2025 by the Institute of Directors (IOD), India.   This honor recognizes organizations that demonstrate the highest standards of governance, ethics, and transparency. The evaluation was led by a distinguished jury chaired by Hon’ble Mr. Justice Uday U. Lalit (Retd.), former Chief Justice of India, along with Hon’ble Justice Ritu Raj Awasthi, judicial member, Lokpal of India, and Prof. (Judge) Mervyn E. King SC, Chair Emeritus, IIRC and GRI. The award was presented at IOD India’s Annual Global Convention on Corporate Governance & Sustainability in London. This recognition is especially meaningful as Biocon Biologics is the only pharmaceutical company to be honored this year, and one of the few privately held enterprises recognized alongside listed companies.   Shreehas Tambe , CEO & Managing Director, said: "Winning the Golden Peacock Award for Excellence in Corporate Governance is a proud milestone for Biocon Biologics and a powerful affirmation of our unwavering commitment to transparency, ethics, and accountability. At Biocon Biologics, we believe that strong governance is the cornerstone of sustainable growth and stakeholder trust. This recognition is a testament to the collective dedication of our Board, leadership team, and employees to uphold the highest standards of integrity and responsibility. As we continue to expand our global presence, we remain focused on embedding governance into every facet of our operations, ensuring we not only meet, but consistently exceed expectations of our stakeholders worldwide.”   Akhilesh Nand , Global Head – Governance, Risk & Compliance and Company Secretary, added: “At Biocon Biologics, governance is part of our culture. This award reflects the collective commitment of our teams to uphold the highest standards of integrity, accountability, and transparency.”  As we continue to expand our global footprint, we remain committed to strengthening a governance framework that supports responsible growth and long-term value creation for all stakeholders.   #BioconBiologics #CorporateGovernance #GoldenPeacockAwards #Sustainability #Leadership #ESG #GovernanceExcellence #EthicalBusiness Kedar Upadhye Arun Kasat (LL.M, CA, FAFD) Tinku Padia David Stollman Sharad Jain Anil Kumar Panchariya

We often notice every little alert on our screens - but can miss the subtle ones from our own body.   Excessive fatigue and/or thirst, slow healing - these are small signs that can mean something more.   This Diabetes Awareness Month, take a moment to VIEW what your body may be saying.   Because the earlier diabetes is recognized, the easier it is to manage, control, and even prevent. #ClickRightOnDiabetes #BioconBiologics #DiabetesAwareness #DiabetesEducation #KnowYourNumbers #EarlyDetection #GlucoseManagement #ChronicCare #PatientAwareness #HealthcareEducation

Every day, we click & open countless tabs, apps, and conversations online, but some topics deserve more space in our lives. This Diabetes Awareness Month, let’s open conversations that can save lives. Because awareness is the first click towards change. #BioconBiologics #ClickRight #DiabetesAwareness #DiabetesEducation #KnowYourNumbers #EarlyDetection #GlucoseManagement #ChronicCare #PatientAwareness #HealthcareEducation

Every day, we click our way through countless things - updates, reminders, stories. But somewhere in all that motion, we forget to pause and check in with ourselves. Click Right is a reminder to bring that same awareness to our health - to notice, reflect, and act before it’s too late. When it comes to diabetes, even one small click - a test, a lifestyle change, a conversation - can make all the difference. This Diabetes Awareness Month, and every month, let’s choose to Click Right on diabetes - to stay aware, stay proactive, and stay connected to what truly matters: our health. #BioconBiologics #ClickRight #DiabetesAwareness #DiabetesEducation #KnowYourNumbers #EarlyDetection #GlucoseManagement #ChronicCare #PatientAwareness #HealthcareEducation

Did you know that biosimilars have the potential to save the Canadian healthcare system more than $1.8 billion each year (source: Canada's Patented Medicine Prices Review Board)? With a growing portfolio of monoclonal antibodies, insulins and recombinant proteins developed for therapeutic areas such as diabetes, cancer, and autoimmune conditions, Biocon Biologics is committed to supporting broader access and healthcare sustainability. Our home base in Canada is Toronto, and we are proud to have team members in provinces across the country. Our commitment to improving healthcare access is reflected through our partnerships with organizations like Biosimilars Canada | Biosimilaires Canada , Health Canada | Santé Canada , and the Canadian Association for Pharmacy Distribution Management (CAPDM) , among others. #BioconBiologicsAroundtheWorld #BioconBiologicsCanada #Biosimilars #HealthcareAccess #Biologics #InnovationInHealthcare #BioconBiologicsNorthAmerica

Biocon Biologics delivered robust revenue growth in Q2FY26, driven by sustained demand across key markets. This momentum translated into significant improvement in profitability for the quarter. #BioconBiologics #FinancialPerformance #AccessToHealthcare #SustainableGrowth #GlobalHealth #Earnings